Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haydar Bulut

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Elife|October 18, 2017
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potencyManabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, et al.
Nature Communications|January 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replicationShin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, et al.
PNAS Nexus|January 20, 2025
An orally available P1'-5-fluorinated M<sup>pro</sup> inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrierNobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi, et al.
Nature Communications|February 25, 2023
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, et al.
The Journal of Experimental Medicine|May 13, 2022
GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humansYikun Yao, Ping Du Jiang, Brittany N Chao, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Elife|October 18, 2017
A novel central nervous system-penetrating protease inhibitor overcomes human immunodeficiency virus 1 resistance with unprecedented aM to pM potencyManabu Aoki, Hironori Hayashi, Kalapala Venkateswara Rao, et al.
Nature Communications|January 29, 2021
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replicationShin-Ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, et al.
PNAS Nexus|January 20, 2025
An orally available P1'-5-fluorinated M<sup>pro</sup> inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrierNobuyo Higashi-Kuwata, Haydar Bulut, Hironori Hayashi, et al.
Nature Communications|February 25, 2023
Identification of SARS-CoV-2 M<sup>pro</sup> inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2Nobuyo Higashi-Kuwata, Kohei Tsuji, Hironori Hayashi, et al.
The Journal of Experimental Medicine|May 13, 2022
GIMAP6 regulates autophagy, immune competence, and inflammation in mice and humansYikun Yao, Ping Du Jiang, Brittany N Chao, et al.
Pageof 4